Please use this identifier to cite or link to this item: http://dl.umsu.ac.ir/handle/2144/2500
Title: Genome-Wide Significance for a Modifier of Age at Neurological Onset in Huntington's Disease at 6q23-24: The HD MAPS Study
Authors: Li, Jian-Liang;Hayden, Michael R;Warby, Simon C;Durr, Alexandra;Morrison, Patrick J;Nance, Martha;Ross, Christopher A;Margolis, Russell L;Rosenblatt, Adam;Squitieri, Ferdinando;Frati, Luigi;Gómez-Tortosa, Estrella;García, Carmen Ayuso;Suchowersky, Oksana;Klimek, Mary Lou;Trent, Ronald JA;McCusker, Elizabeth;Novelletto, Andrea;Frontali, Marina;Paulsen, Jane S;Jones, Randi;Ashizawa, Tetsuo;Lazzarini, Alice;Wheeler, Vanessa C;Prakash, Ranjana;Xu, Gang;Djoussé, Luc;Mysore, Jayalakshmi Srinidhi;Gillis, Tammy;Hakky, Michael;Cupples, L Adrienne;Saint-Hilaire, Marie H;Cha, Jang-Ho J;Hersch, Steven M;Penney, John B;Harrison, Madaline B;Perlman, Susan L;Zanko, Andrea;Abramson, Ruth K;Lechich, Anthony J;Duckett, Ayana;Marder, Karen;Conneally, P Michael;Gusella, James F;MacDonald, Marcy E;Myers, Richard H
Year: 2006
17-Aug-2006
Publisher: BioMed Central
Description: BACKGROUND: Age at onset of Huntington's disease (HD) is correlated with the size of the abnormal CAG repeat expansion in the HD gene; however, several studies have indicated that other genetic factors also contribute to the variability in HD age at onset. To identify modifier genes, we recently reported a whole-genome scan in a sample of 629 affected sibling pairs from 295 pedigrees, in which six genomic regions provided suggestive evidence for quantitative trait loci (QTL), modifying age at onset in HD. METHODS: In order to test the replication of this finding, eighteen microsatellite markers, three from each of the six genomic regions, were genotyped in 102 newly recruited sibling pairs from 69 pedigrees, and data were analyzed, using a multipoint linkage variance component method, in the follow-up sample and the combined sample of 352 pedigrees with 753 sibling pairs. RESULTS: Suggestive evidence for linkage at 6q23-24 in the follow-up sample (LOD = 1.87, p = 0.002) increased to genome-wide significance for linkage in the combined sample (LOD = 4.05, p = 0.00001), while suggestive evidence for linkage was observed at 18q22, in both the follow-up sample (LOD = 0.79, p = 0.03) and the combined sample (LOD = 1.78, p = 0.002). Epistatic analysis indicated that there is no interaction between 6q23-24 and other loci. CONCLUSION: In this replication study, linkage for modifier of age at onset in HD was confirmed at 6q23-24. Evidence for linkage was also found at 18q22. The demonstration of statistically significant linkage to a potential modifier locus opens the path to location cloning of a gene capable of altering HD pathogenesis, which could provide a validated target for therapeutic development in the human patient.
Public Health Service (P50NS016367, NS16375, NS32765); Canadian Institutes of Health Research; Huntington's Disease Society of America's "Coalition for the Cure"; Jerry McDonald Huntington's Disease Research Fund; National Institutes of Health National Center for Research Resources Shared Instrumentation grant (ISI0RR163736-01A1)
URI: http://creativecommons.org/licenses/by/2.0
http://open.bu.edu/handle/2144/2500
Standard no: Li, Jian-Liang, Michael R Hayden, Simon C Warby, Alexandra Durr, Patrick J Morrison, Martha Nance, Christopher A Ross, Russell L Margolis, Adam Rosenblatt, Ferdinando Squitieri, Luigi Frati, Estrella Gómez-Tortosa, Carmen Ayuso García, Oksana Suchowersky, Mary Lou Klimek, Ronald JA Trent, Elizabeth McCusker, Andrea Novelletto, Marina Frontali, Jane S Paulsen, Randi Jones, Tetsuo Ashizawa, Alice Lazzarini, Vanessa C Wheeler, Ranjana Prakash, Gang Xu, Luc Djoussé, Jayalakshmi Srinidhi Mysore, Tammy Gillis, Michael Hakky, L Adrienne Cupples, Marie H Saint-Hilaire, Jang-Ho J Cha, Steven M Hersch, John B Penney, Madaline B Harrison, Susan L Perlman, Andrea Zanko, Ruth K Abramson, Anthony J Lechich, Ayana Duckett, Karen Marder, P Michael Conneally, James F Gusella, Marcy E MacDonald, Richard H Myers. "Genome-wide significance for a modifier of age at neurological onset in Huntington's Disease at 6q23-24: the HD MAPS study." BMC Medical Genetics 7:71. (2006)
1471-2350
10.1186/1471-2350-7-71
16914060
1586197
Appears in Collections:School of Medicine

Files in This Item:
Click on the URI links for accessing contents.


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.